In the context of this condition, we concluded that COX-2+ cancer cells could be a critical co-factor in the poor prognosis caused by MUC2 overexpression in addition to MUC2-induced COX-2+ and M2 TAMs. This evidence concerns the gene MUC2 and cancer.